How and when to use biologics in psoriasis.
Kircik
Leon H
LH
Mount Sinai Medical Center, NewYork, NY, USA. wedoderm@bellsouth.net
Gonzalez
Mercedes E
ME
D000077944:Alefacept; D001688:Biological Products / Q000009:adverse effects / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use; D016903:Drug Monitoring; D006801:Humans; D011565:Psoriasis / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D001688:Biological Products; D003879:Dermatologic Agents; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha; D000077944:Alefacept